A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging

Radiographics

Volumn 29, Issue 1, 2009, Pages 89-103

  Cummings, Kristopher W ^a   Bhalla, Sanjeev ^a   Javidan Nejad, Cylen ^a   Bierhals, Andrew J ^a   Gutierrez, Fernando R ^a   Woodard, Pamela K ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; DOSE RESPONSE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE ENHANCEMENT; INFANT; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; AGED; CARDIOMYOPATHIES; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 63049094866     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.291085052     Document Type: Article

References (32)

1. Borchert B, Lawrenz T, Bartelsmeier M, Rothemeyer S, Kuhn H, Stellbrink C. Utility of endomyocardial biopsy guided by delayed enhancement areas on magnetic resonance imaging in the diagnosis of cardiac sarcoidosis. Clin Res Cardiol 2007;96(10): 759-762.
2. Vogelsberg H, Mahrholdt H, Deluigi C, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008;51(10):1022-1030.
3. Rehwald WG, Fieno DS, Chen E, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105(2): 224-229.
4. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111(2):186-193.
5. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337(13):898-909.
6. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology 2001;218(3):703-710.
7. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94(12):3318-3326.
8. Krombach GA, Hahn C, Tomars M, et al. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. J Magn Reson Imaging 2007;25(6):1283-1287.
9. Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007;27 (3):457-475.
10. Edelman RR. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology 2004; 232(3):653-668.
11. Takahashi N, Murakami Y, Shimada T, et al. Detection of eosinophilic myocarditis using contrastenhanced magnetic resonance imaging: case report. Can Assoc Radiol J 2001;52(1):20-22.
12. Heatlie GJ, Mohiaddin R. Left ventricular aneurysm: comprehensive assessment of morphology, structure and thrombus using cardiovascular magnetic resonance. Clin Radiol 2005;60(6):687-692.
13. Kumbasar B, Wu KC, Kamel IR, Lima JA, Bluemke DA. Left ventricular true aneurysm: diagnosis of myocardial viability shown on MR imaging. AJR Am J Roentgenol 2002;179(2):472-474.
14. Shehata BM, Patterson K, Thomas JE, Scala-Barnett D, Dasu S, Robinson HB. Histiocytoid cardiomyopathy: three new cases and a review of the literature. Pediatr Dev Pathol 1998;1(1):56-69.
15. Zangwill SD, Trost BA, Zlotocha J, Tweddell JS, Jaquiss RD, Berger S. Orthotopic heart transplantation in a child with histiocytoid cardiomyopathy. J Heart Lung Transplant 2004;23(7):902-904.
16. Kim RJ, Wu E, Rafael A, et al. The use of contrastenhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343(20):1445-1453.
17. Vogel-Claussen J, Rochitte CE, Wu KC, et al. Delayed enhancement MR imaging: utility in myocardial assessment. RadioGraphics 2006;26(3): 795-810.
18. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26(15):1461-1474.
19. Liu PP, Schultheiss HP. Myocarditis. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed. Philadelphia, Pa: Saunders Elsevier, 2008; 1775.
20. Laissy JP, Messin B, Varenne O, et al. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest 2002;122(5): 1638-1648.
21. Ordovas KG, Reddy GP, Higgins CB. MRI in nonischemic acquired heart disease. J Magn Reson Imaging 2008;27(6):1195-1213.
22. Mahrholdt H, Goedecke C, Wagner A. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109(10):1250-1258.
23. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287(10):1308-1320.
24. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108(1):54-59.
25. Nazarian S, Bluemke DA, Lardo AC, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112(18):2821-2825.
26. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005;184(1):249-254.
27. Hare JM. The dilated, restrictive, and infiltrative cardiomyopathies. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed. Philadelphia, Pa: Saunders Elsevier, 2008; 1755-1756.
28. Matoh F, Satoh H, Shiraki K, et al. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J Cardiol 2008; 51(3):179-188.
29. Jassal DS, Nomura CH, Neilan TG, et al. Delayed enhancement cardiac MR imaging in noncompaction of left ventricular myocardium. J Cardiovasc Magn Reson 2006;8(3):489-491.
30. Weiford BC, Subbarao VD, Mulhern KM. Noncompaction of the ventricular myocardium. Circulation 2004;109(24):2965-2971.
31. Bybee KA, Kara T, Prasad A, et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004;141(11): 858-865.
32. Syed IS, Prasad A, Oh JK, et al. Apical ballooning syndrome or aborted acute myocardial infarction? insights from cardiovascular magnetic resonance imaging. Int J Cardiovasc Imaging 2008 May 27 [Epub ahead of print].